European Union - English - EMA (European Medicines Agency)

takeda manufacturing austria ag - human protein c - purpura fulminans; protein c deficiency - antithrombotic agents - ceprotin is indicated for prophylaxis and treatment of  purpura fulminans  coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxalta uk ltd - protein c - powder and solvent for solution for injection - 500unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxalta uk ltd - protein c - powder and solvent for solution for injection - 1000unit

Israel - English - Ministry of Health

kamada ltd, israel - plasma protein fraction - solution for infusion - plasma protein fraction 200 mg/ml - protein c - protein c - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendation.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

baxter ag - austria, austria - protein c - powder for solution for injection/infusion - 1000 iu

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

takeda manufacturing ag, austria - protein c - powder for solution for injection or infusion - 500 iu

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

takeda manufacturing ag, austria - protein c - powder for solution for injection/infusion - 500 iu